Skip to main content
. 2019 Mar 29;29(2):82–91. doi: 10.1089/nat.2018.0754

FIG. 1.

FIG. 1.

IONIS-PKKRx reduces expression of human mRNA in HepaRG human hepatoma cells and transgenic mice. (A) IONIS-PKKRx inhibits PKK mRNA expression in HepaRG human hepatoma cells. Data are presented as mean ± SEM (N = 3). Control ASO sequence: 5′-CCTTCCCTGAAGGTTCCTCC-3; underline denotes 2′MOE-modified nucleotides. (B) Liver hPKK mRNA expression in hPKK-Tg mice after 3 weeks of IONIS-PKKRx treatment. (C) Plasma hPKK levels in hPKK-Tg mice after 3 weeks of IONIS-PKKRx treatment. ASO, antisense oligonucleotides; hPKK-Tg, human PKK transgenic; 2′MOE, 2′-O-(2-methoxyethyl).